vaccines
US FDA approves HPV vaccine for men and women aged 27-45
October 8, 2018Sales and Marketing CDC, Cancer, FDA, HPV, approval, infectious diseases, vaccines
The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman …
Rates of vaccination decline in England, study shows
September 18, 2018Manufacturing and Production England, NHS, health, public health, vaccines, vacinnation
The number of people who are receiving the 12 routine childhood vaccinations has declined in proportion to the eligible population …
Russian trolls spread vaccine misinformation on Twitter
August 28, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines
Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …
Rotavirus vaccine shown to reduce risk of death by 34% in Malawi
August 15, 2018Research and Development Rotavirus, diarrhoea, malawi, vaccination program, vaccines
A rotavirus vaccine was successful in reducing diarrhoea related deaths in infants in Malawi by 34%, a study led by …
HPV vaccine to be given to boys in England
July 25, 2018Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus
The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …
Chinese premier slams drug maker after vaccine scandal
July 23, 2018Sales and Marketing CCP, China, biotech, scandal, vaccines
Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …
Sanofi to invest €350m in new Canadian vaccine plant
April 12, 2018Manufacturing and Production Canada, Sanofi, pharma, vaccines
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, …
Top Ten most popular articles on Pharmafile.com this week
March 2, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines
We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …
Sanofi launches dengue immunisation program in Brazil
August 15, 2016Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines
Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
FDA to review investigational hepatitis B vaccine
April 1, 2016Medical Communications, Research and Development dynavax, hepatitis B, vaccines
Dynavax Technologies (NASDAQ: DVAX) says the FDA has accepted for review the company’s investigational adult hepatitis B vaccine, HEPLISAV-B. The FDA has set …
Thirty-seven arrested in China vaccine scandal
March 23, 2016Sales and Marketing China, vaccines
Police in China have arrested 37 people in eastern China in relation to illegal vaccine sales conducted by a ring …
Sanofi Pasteur and MSD end European vaccines partnership
March 8, 2016Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines
Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
INTERVIEW: Tackling the Zika threat
February 9, 2016Manufacturing and Production, Medical Communications Zika, vaccines
The Zika outbreak which started in Brazil and spread rapidly to other south American countries and beyond has taken the …
Sanofi Pasteur to join the Human Vaccines Project
January 15, 2016Medical Communications, Research and Development Human Vaccines Project, Sanofi Pasteur, vaccines
Sanofi Pasteur has become the latest pharma company to add funding to The Human Vaccines Project – a non-profit public-private …
MSF launches global action against GSK and Pfizer over pneumonia vaccine price
November 12, 2015Manufacturing and Production, Sales and Marketing Doctors Without Borders, GSK, MSF, Médecins Sans Frontières, Pfizer, Synflorix, pneumococcal vaccine, pneumonia, prevenar 13, vaccines
International medical aid charity Médecins Sans Frontières/Doctors Without Borders (MSF) is taking action against GlaxoSmithKline and Pfizer, calling on the …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
